替尔泊肽卖爆了!销量暴增46%,礼来第二季度盈利超预期

GLP1减重宝典
Aug 10

整理 | GLP1减重宝典内容团队礼来公司(LLY)周四公布二季度业绩优于市场预期,但备受关注的口服 GLP-1 药物试验结果令人失望,导致股价在周四早盘下跌 13%。礼来本季度营收达 155.6 亿美元,高于华尔街预期的 146.9 亿美元;每股收益 6.31 美元,也高于市场预测的 5.56 美元。美国市场营收 108.1 亿美元,其中 GLP-1 药物 Mounjaro(替尔泊肽)与 ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10